Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2026 · 10-Q
Revenue$283.44M$283.44M−2.4% vs Q3 2025 Net Income$46.70M$46.70M−23.5% vs Q3 2025 EPS Diluted$0.97$0.97−20.5% vs Q3 2025 Gross Profit$157,369,000−2.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$78,287,000+20.3% Free Cash Flowderived$75,259,000+18.5% Margins · derivedGross margin55.5%+0.0 pt vs Q3 2025
Operating margin29.1%−2.6 pt vs Q3 2025
Net margin16.5%−4.5 pt vs Q3 2025
ended Dec 31, 2025 · filed Feb 5, 2026 · 36 d after period end